{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:28:03Z","timestamp":1784348883398,"version":"3.55.0"},"reference-count":88,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM122806"],"award-info":[{"award-number":["GM122806"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Cushing\u2019s syndrome (CS) is an endocrine disease characterized by excessive adrenocortical steroid production. One of the mainstay pharmacological treatments for CS are steroidogenesis enzyme inhibitors, including the antifungal agent ketoconazole along with metyrapone, mitotane, and aminoglutethimide. Recently, osilodrostat was added to this drug class and approved by the US Food and Drug Administration (FDA) for the treatment of Cushing\u2019s Disease. Steroidogenesis enzyme inhibitors inhibit various enzymes along the cortisol biosynthetic pathway and may be used preoperatively to lower cortisol levels and reduce surgical risk associated with tumor resection or postoperatively when surgery and\/or radiation therapies are not curative. Because their selectivities for steroidogenic enzymes vary, they may even be administered in combination to achieve relatively rapid control of severe hypercortisolemia. Unfortunately, all currently available inhibitors are accompanied by serious adverse side effects that limit dosing and often result in treatment failures. Although more commonly known as a general anesthetic induction agent, etomidate is another member of the steroidogenesis enzyme inhibitor drug class. It suppresses cortisol production primarily by inhibiting 11\u03b2-hydroxylase and is the only inhibitor that may be given parenterally. However, the sedative-hypnotic actions of etomidate limit its use as an acute management option for CS. Thus, some have recommended that it be used only in intensive care settings. In this review, we discuss the initial development of etomidate as an anesthetic agent, its subsequent development as a treatment for CS, and the recent advances in dosing and drug development that dissociate sedative-hypnotic and adrenostatic drug actions to facilitate CS treatment in non-critical care settings.<\/jats:p>","DOI":"10.1177\/20420188211058583","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T07:02:56Z","timestamp":1644822176000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate"],"prefix":"10.1177","volume":"13","author":[{"given":"Andrea","family":"Pence","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Lee","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-978X","authenticated-orcid":false,"given":"Douglas E.","family":"Raines","sequence":"additional","affiliation":[{"name":"Edward Mallinckrodt Jr. Professor of Anaesthesiology in the Field of Pharmacology and Innovation, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"bibr1-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0098-2"},{"key":"bibr2-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1159\/000314317"},{"key":"bibr3-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01128-7"},{"key":"bibr4-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14014"},{"key":"bibr5-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1159\/000314292"},{"key":"bibr6-20420188211058583","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S12952"},{"key":"bibr7-20420188211058583","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111951"},{"key":"bibr8-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1177\/000456328602300301"},{"key":"bibr9-20420188211058583","first-page":"259","volume":"240","author":"Lamberts SW","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr10-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0274"},{"key":"bibr11-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0300"},{"key":"bibr12-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12345"},{"key":"bibr13-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0462-4"},{"key":"bibr14-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1269-1"},{"key":"bibr15-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1014"},{"key":"bibr16-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00269"},{"key":"bibr17-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.245332"},{"key":"bibr18-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-019-0328-4"},{"key":"bibr19-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb03883.x"},{"key":"bibr20-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1159\/000083476"},{"key":"bibr21-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032180"},{"key":"bibr22-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02380.x"},{"key":"bibr23-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2734"},{"key":"bibr24-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0117-3"},{"key":"bibr25-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1048"},{"key":"bibr26-20420188211058583","first-page":"476","volume":"13","author":"Gheorghiu ML","year":"2017","journal-title":"Acta Endocrinol"},{"key":"bibr27-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0633-2"},{"key":"bibr28-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/685213"},{"key":"bibr29-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2019.05.007"},{"key":"bibr30-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1533"},{"key":"bibr31-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0264-1"},{"key":"bibr32-20420188211058583","first-page":"188","volume":"3","author":"Ji Y","year":"2016","journal-title":"Neurooncol Pract"},{"key":"bibr33-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0662"},{"key":"bibr34-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30326-1"},{"key":"bibr35-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2012.06.012"},{"key":"bibr36-20420188211058583","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2018.14.2.62"},{"key":"bibr37-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2117"},{"key":"bibr38-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0692-z"},{"key":"bibr39-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"bibr40-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1976.tb01504.x"},{"key":"bibr41-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0358"},{"key":"bibr42-20420188211058583","unstructured":"Administration FDA. FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems, https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially (2013, accessed 31 March 2021)."},{"key":"bibr43-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01103-6"},{"key":"bibr44-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0913"},{"key":"bibr45-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0557"},{"key":"bibr46-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0147"},{"key":"bibr47-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1021\/jm00326a017"},{"key":"bibr48-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0611fje"},{"key":"bibr49-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706441"},{"key":"bibr50-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181ff72b5"},{"key":"bibr51-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.479725"},{"key":"bibr52-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.01.003"},{"key":"bibr53-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/52.8.731"},{"key":"bibr54-20420188211058583","first-page":"157","volume":"202","author":"Marietta MP","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr55-20420188211058583","first-page":"1234","volume":"21","author":"Janssen PA","year":"1971","journal-title":"Arzneimittelforschung"},{"key":"bibr56-20420188211058583","first-page":"92","volume":"214","author":"Janssen PA","year":"1975","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"bibr57-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1982.tb01319.x"},{"key":"bibr58-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92712-5"},{"key":"bibr59-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1984.tb08885.x"},{"key":"bibr60-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90052-2"},{"key":"bibr61-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-59-6-1143"},{"key":"bibr62-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405313102202"},{"key":"bibr63-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-007-9128-9"},{"key":"bibr64-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181cf40ed"},{"key":"bibr65-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001304"},{"key":"bibr66-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(93)90054-Q"},{"key":"bibr67-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1983.tb15175.x"},{"key":"bibr68-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1021\/jm020465v"},{"key":"bibr69-20420188211058583","first-page":"3542","volume":"83","author":"Drake WM","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr70-20420188211058583","first-page":"4104","volume":"86","author":"Krakoff J","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr71-20420188211058583","first-page":"140","volume":"64","author":"Greening JE","year":"2005","journal-title":"Horm Res"},{"key":"bibr72-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e318187ed37"},{"key":"bibr73-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181e47b7a"},{"key":"bibr74-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1177\/2042018819825541"},{"key":"bibr75-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-5-1426"},{"key":"bibr76-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.618"},{"key":"bibr77-20420188211058583","volume":"4","author":"Matheny LN","year":"2016","journal-title":"J Investig Med High Impact Case Rep"},{"key":"bibr78-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1159\/000324419"},{"key":"bibr79-20420188211058583","first-page":"150051","volume":"2015","author":"Bucciarelli M","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"bibr80-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-405"},{"key":"bibr81-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/56.1.19"},{"key":"bibr82-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0380"},{"key":"bibr83-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000416"},{"key":"bibr84-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400110137026"},{"key":"bibr85-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199508000-00035"},{"key":"bibr86-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0698"},{"key":"bibr87-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90811-1"},{"key":"bibr88-20420188211058583","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13414"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188211058583","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420188211058583","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188211058583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:35:49Z","timestamp":1777592149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420188211058583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":88,"alternative-id":["10.1177\/20420188211058583"],"URL":"https:\/\/doi.org\/10.1177\/20420188211058583","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20420188211058583"}}